EGFR and non-small cell lung carcinoma: Li et al. developed an adoptive T-cell therapy to target the human epidermal growth factor receptor (EGFR) in non-small cell lung cancer by expressing a chimeric antigen receptor (CAR) utilizing a non-viral piggy Bac transposon technology.